KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÇÑÀÚ
localization
±¹¼ÒÈ, À§Ä¡¼±Á¤, ÇѰ÷¸ðÀÓ
ÏÑá¶ûù, êÈöÇàÔïÒ
cerebral cortical l.
³ú°ÑÁú±â´ÉÀ§Ä¡È
³ú°ÑÁúѦÒöêÈöÇûù
luxury perfusion
ȣȰü·ù
ûßü¤Î´×µ
¤Ñ activated killer cells (LAK cell)
¸²Æ÷Ä«ÀÎȰ¼ºÈ»ìÇØ¼¼Æ÷
¸²Æ÷Ä«ÀÎüÀàõûù߯úªá¬øà
mapping
ÁöµµÈ
ò¢Óñûù
brain m.
³úÁöµµÈ
Òàò¢Óñûù
¤Ñ sclerosis
´Ù¹ß¼º°æÈÁõ
ÒýÛ¡àõÌãûùñø
myelomalacia
ô¼ö¿¬È(Áõ)
ô±âÐæãûù(ñø)
myositis ossificans
°ñȱÙÀ°¿°, °ñȼº±Ù¿°
ÍéûùÐÉë¿æú, ÍéûùàõÐÉæú
neoadjuvant chemotherapy
½Åº¸°ÈÇпä¹ý
ãæÜÍËûùùÊèþÛö
neuroaugmentation
½Å°æ°È, ½Å°æÃËÁø
ãêÌèËûù, ãêÌèõµòä
¤Ñ deterioration
½Å°æ(ÇÐÀû)¾ÇÈ
ãêÌè(ùÊîÜ)äÂûù
ossification
»ÀµÇ±â, °ñÈ
Íéûù
ossification of yellow ligament (OLY), ossificatio
Ȳ»öÀδë»ÀµÇ±âÁõ, Ȳ»öÀδë°ñÈÁõ
üÜßäìåÓáÍéûùñø
ossification of posterior longitudinal ligament (O
µÚ¼¼·ÎÀδë»ÀµÇ±âÁõ, ÈÄÁ¾Àδë°ñÈÁõ
ýðýìåÓáÍéûùñø
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½